Sverica Capital Management acquired a majority interest in Gener8, a Sunnyvale, CA-based company that designs and manufactures life science instrumentation, complex clinical devices as well as advanced industrial systems, leveraging expertise in microfluidics, optics, electronics and embedded systems.
The amount of the deal was not disclosed.
Founded in 2002 by David Klein, CEO, Gener8 has capabilities including end-to-end design, development, prototype and low-to-medium volume manufacturing.
The company maintains facilities and an engineering team with more than 30 PhDs spanning a multitude of disciplines, including electrical, mechanical, software, optical and systems engineering.
Sverica is a lower-middle-market-focused private equity firm that has raised over $700 million of investment capital across four funds. The firm acquires and actively builds companies that are, or could become, leaders in their industries.